Our achievements would not be possible without the outstanding team that make up Shield Therapeutics’ staff, management and board of directors.


Hans Peter Hasler

Mr Hasler joined the Board of Shield Therapeutics plc  in July 2018. He is the founder and CEO of Vicarius Pharma and an Advisor to SBTech Global Advisory. His prior experience includes roles as COO, Elan Corporation, and several senior positions at Biogen, Inc., including Chief Operations Officer. Previously, Mr. Hasler was at Wyeth Pharmaceuticals as Senior Vice President, Chief Marketing Officer and Managing Director of Wyeth Group Germany, Wyeth-Lederle Switzerland, Austria and CEE. Mr Hasler is Chairman of HBM Healthcare Investments AG in Switzerland, Chairman of MIAC Medical Imaging Analysis Center of the University Hospital of Basel, and a Director of the Board of Minerva Neuroscience Inc., Boston.

Back to team